Open Collections

Hernandez Cordero, Ana I.; Li, Xuan; Yang, Chen Xi; Yang, Julia; MacIsaac, Julia L.; Dever, Kristy; Kobor, Michael S.; Milne, Stephen; van Eeden, Stephan F.; Shaipanich, Tawimas; Lam, Stephen; Leung, Janice M.; Sin, Don D.

Multidisciplinary Digital Publishing Institute

Epigenetic modifications are common in chronic obstructive pulmonary disease (COPD); however, their clinical relevance is largely unknown. We hypothesized that epigenetic disruptions are associated with symptoms and health status in COPD. We profiled the blood (n = 57) and airways (n = 62) of COPD patients for DNA methylation (n = 55 paired). The patients’ health status was assessed using the St. George’s Respiratory Questionnaire (SGRQ). We conducted differential methylation analyses and identified pathways characterized by epigenetic disruptions associated with SGRQ scores and its individual domains. 29,211 and 5044 differentially methylated positions (DMPs) were associated with total SGRQ scores in blood and airway samples, respectively. The activity, impact, and symptom domains were associated with 9161, 25,689 and 17,293 DMPs in blood, respectively; and 4674, 3730 and 5063 DMPs in airways, respectively. There was a substantial overlap of DMPs between airway and blood. DMPs were enriched for pathways related to common co-morbidities of COPD (e.g., ageing, cancer and neurological) in both tissues. Health status in COPD is associated with airway and systemic epigenetic changes especially in pathways related to co-morbidities of COPD. There are more blood DMPs than in the airways suggesting that blood epigenome is a promising source to discover biomarkers for clinical outcomes in COPD.

Article

eng

Vancouver : University of British Columbia Library

10.14288/1.0447627

Medicine, Faculty of; Non UBC; Medical Genetics, Department of; Medicine, Department of

10.3390/biomedicines11010134

Faculty; Researcher

DSpace